5:19 PM · 5 February 2024

MorphoSys gains 37% amid rumours of possible takeover by Novartis

Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.

The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.

MorphoSys shares are currently gaining nearly 37%.

Source: xStation

14 July 2026, 3:17 PM

US Open: Nasdaq 100 gains 1% 🔼 Software stocks decline, JP Morgan rises after earnings

14 July 2026, 1:52 PM

Software stocks slide on enterprise spending concerns 🚩 Microsoft drops 3%

14 July 2026, 1:52 PM

Goldman Sachs Wins, Citigroup Loses: Why the Market Viewed Two Strong Earnings Reports Differently

14 July 2026, 1:42 PM

Worse than the Dot-com bubble: IBM stock crash

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits